Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia.

Guo J, Meng F, Ma N, Li C, Ding Z, Wang H, Hou R, Qin Y.

Am J Cardiol. 2012 Nov 1;110(9):1296-301. doi: 10.1016/j.amjcard.2012.06.050. Epub 2012 Jul 27. Review.

PMID:
22840347
2.

Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.

Geng Q, Ren J, Chen H, Lee C, Liang W.

Clin Exp Pharmacol Physiol. 2013 Mar;40(3):219-26. doi: 10.1111/1440-1681.12053.

PMID:
23324122
3.

Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.

Geng Q, Ren J, Chen H, Lee C, Liang W.

Curr Med Res Opin. 2013 Mar;29(3):181-8. doi: 10.1185/03007995.2013.766592. Epub 2013 Feb 6.

PMID:
23323878
4.

Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials.

Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstøl K, Bryniarski L, Császár A, Vanderbist F.

Clin Drug Investig. 2012 Apr 1;32(4):281-91. doi: 10.2165/11630820-000000000-00000.

PMID:
22350498
5.

Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.

Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A.

Ann Pharmacother. 2011 Oct;45(10):1230-9. doi: 10.1345/aph.1Q110. Epub 2011 Sep 13.

PMID:
21917557
6.

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.

Ellen RL, McPherson R.

Am J Cardiol. 1998 Feb 26;81(4A):60B-65B. Review.

PMID:
9526816
7.

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.

Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P.

Clin Ther. 2007 Feb;29(2):253-60.

PMID:
17472818
8.

[Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].

Kłosiewicz-Latoszek L, Respondek W, Białobrzeska-Paluszkiewicz J, Grzybowska B, Jakóbisiak-Ostasz B, Stolarska I.

Pol Merkur Lekarski. 2003 Jul;15(85):42-6. Polish.

PMID:
14593958
9.

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.

Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, Choi IS, Shin EK.

J Am Coll Cardiol. 2005 May 17;45(10):1649-53.

10.

Safety considerations with fenofibrate/simvastatin combination.

Filippatos TD, Elisaf MS.

Expert Opin Drug Saf. 2015;14(9):1481-93. doi: 10.1517/14740338.2015.1056778. Epub 2015 Jul 3. Review.

PMID:
26134595
11.
12.

Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.

Koh KK, Quon MJ, Rosenson RS, Chung WJ, Han SH.

Int J Cardiol. 2008 Feb 29;124(2):149-59. Epub 2007 Jul 20. Review.

13.

One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.

Ferdinand KC, Davidson MH, Kelly MT, Setze CM.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):117-25. doi: 10.2165/11597940-000000000-00000.

PMID:
22263674
15.

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.

Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators.

Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007.

PMID:
20110022
16.

Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy.

Farnier M, Ducobu J, Bryniarski L.

Am J Cardiol. 2010 Sep 15;106(6):787-92. doi: 10.1016/j.amjcard.2010.05.005. Epub 2010 Aug 2.

PMID:
20816118
17.

[Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia].

Ren JY, Chen H, Luo Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):122-6. Chinese.

PMID:
15924805
18.

[A meta-analysis on the safety of combination therapy with fenofibrate and statins].

Geng Q, Ren JY, Li SF, Chen H.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Dec;41(12):1063-8. Chinese.

PMID:
24524615
19.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

20.

Statin-fibrate combination therapy.

Shek A, Ferrill MJ.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):908-17. Review.

PMID:
11485144
Items per page

Supplemental Content

Write to the Help Desk